730078Development of Cannula Dressing Aiding Venous Distension (Vacuderm)ClosedLegacy RDA Grant for R&DInnovate UKIntravenous cannulation- (i.e. inserting a tube) is the most widely performed invasive medical procedure. Intravenous cannulation is needed for giving medication, fluids and bloods to patients across the globe. In England, the NHS purchased approximately 24 million cannulae and the global figure is estimated to be 30 times this. The cannula once inserted is fixed to the skin by a dressing. The global market for cannula dressing is 70 million dollars. The insertion failure rate in cannulation depends on the patient population, but in medical literature in certain studies, first time failure rate is of the order of 25%. This can be much higher in certain patients such as chemotherapy patients or neonates. Hence difficulty in cannulation is a common and ubiquitous medical problem. The product being developed directly addresses this unmet need. We are developing a surgical cannulation dressing with an integrated and detachable vein inflation system ('Vacuderm') in order to make vein cannulation easier and improve the success rate. This development project aims to address the manufacturing issues, clinical trials, continuing international Intellectual Property registration, CE marking and the preparation for market entry including website set up and some early development of training and promotional material for the Vacuderm. The output will be the product Vacuderm, a mass manufactured, CE marked, Clinically tested, IP rights continuing to be registered, Branded, Trade mark protected product ready for market entry initially in the UK and then in the international market.